Document Detail

Management of first-trimester complications in the emergency department.
MedLine Citation:
PMID:  23292263     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: The pharmacologic management and the nonpharmacologic management of first-trimester complications in the emergency department are reviewed.
SUMMARY: The obstetric complications most commonly seen in early pregnancy (less than 20 weeks' gestation) include ectopic pregnancy, threatened and inevitable abortions, and incomplete, complete, and missed abortions. The treatment options for ectopic pregnancy include expectant management, medical management with methotrexate, and surgery. If patients have signs and symptoms of tubal rupture, surgery must be performed immediately. In other cases, the choice of management technique is based on the patient's clinical condition, factors related to the ectopic pregnancy, and the patient's preferences. Pharmacologic therapies for women with confirmed threatened abortion include human chorionic gonadotropin, progesterone, uterine muscle relaxants, and Rh immune globulin prophylaxis. Treatment goals for women whose condition has advanced to inevitable abortion include evacuating any retained products of conception, either with expectant (conservative) management or pharmacologic or surgical intervention. The best treatment option is often determined by the mother's clinical status at the time of presentation and her preference of management strategy. Management of complete abortion may not require any further intervention; however, it is often difficult to identify a complete versus incomplete abortion. Treatment options for complete, incomplete, and missed abortions include expectant, surgical, and medical management.
CONCLUSION: Ectopic pregnancy, threatened and inevitable abortions, and incomplete, complete, and missed abortions are common complications during early pregnancy. Various medical and surgical treatment options are available for managing these complications, including expectant management, medical management, and surgery. Am J Health-Syst Pharm. 2013; 70:99-111.
Umbreen I Murtaza; Melinda J Ortmann; Jennifer Mando-Vandrick; Amy S D Lee
Related Documents :
23551273 - Predictors of large and small for gestational age birthweight in offspring of women wit...
11311763 - Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed durin...
3343273 - Dimensional changes of the feet in pregnancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists     Volume:  70     ISSN:  1535-2900     ISO Abbreviation:  Am J Health Syst Pharm     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503023     Medline TA:  Am J Health Syst Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  99-111     Citation Subset:  IM    
Umbreen I. Murtaza, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Emergency Medicine, Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience.
Next Document:  New oral therapies for the prevention and treatment of venous thromboembolism.